About
Basic Data Updated:
9 days agoStemCyte India Therapeutics Private Limited, a leading cord blood therapeutics company, has been making waves in the medical industry. With a strong presence in both India and international markets, the company has established itself as a pioneer in the field of cord blood transplants. The company's main focus is on storing babies' umbilical cord blood stem cells, which serve as the building blocks for blood, organs, tissue, and the immune system. SITPL, a joint venture between StemCyte Inc. (USA), Apollo Hospital Enterprises Limited, and Cadila Pharmaceuticals Limited, has been at the forefront of revolutionizing the way we approach medical treatments. Through its state-of-the-art cord blood transplant centers, the company has successfully facilitated 47 transplants in more than 12 centers across India. This has not only saved countless lives but has also given hope to families who were previously facing life-threatening illnesses. The company's registered office is located in the bustling city of Ahmedabad, Gujarat, where it continues to make groundbreaking advancements in the field of cord blood therapeutics. StemCyte India Therapeutics Private Limited is committed to providing the best possible care to its patients and is constantly striving to improve and expand its services.
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U85100GJ2008FTC052859 |
| Company No. | 052859 |
| Company Classification | Private Limited Foreign Company Incorporated In India |
| Incorporation Date | 08 Feb 2008 |
| Date of AGM | 11 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Ahmedabad |
Products or Services related to Stemcyte India Therapeutics Private Limited
Medical Facilities
Financials of Stemcyte India Therapeutics Private Limited
Stemcyte India Therapeutics Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 1.22% decrease. The company also saw a substantial fall in profitability, with a 103.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 39.93%.
Corporate Structure
Unlock access to Stemcyte India Therapeutics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Stemcyte India Therapeutics Private Limited
Unlock and access historical data on people associated with Stemcyte India Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
There are no open charges registered against the company as per our records.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stemcyte India Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stemcyte India Therapeutics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Gig - Irm Glass Insulators Private Limited
Active
4 years 8 months Amitabha Banerjee is a mutual person
Apollo Specialty Hospitals Private Limited
Active 14 years 11 months Chandra Chivukula is a mutual person
Recent activity within the organization
Annual General Meeting
Stemcyte India Therapeutics Private Limited last Annual general meeting of members was held on 11 Sep 2023 as per latest MCA records.
11 Sep 2023Balance Sheet
Stemcyte India Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad.
31 Mar 2023Director Appointment
Chandra Sekhar Chivukula was appointed as a Director was appointed as a Director on 28 Oct 2021 & has been associated with this company since 2 years 6 months .
28 Oct 2021Director Appointment
Wise Young was appointed as a Director was appointed as a Director on 27 Mar 2014 & has been associated with this company since 10 years 1 month .
27 Mar 2014Director Appointment
Amitabha Banerjee was appointed as a Director was appointed as a Director on 08 Dec 2011 & has been associated with this company since 12 years 5 months .
08 Dec 2011
Frequently asked questions
What is the Incorporation or founding date of Stemcyte India Therapeutics Private Limited?
